baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

EVOTEC SE/ DE0005664809 /

1/23/2025 3:30:34 PM	Chg. -0.03	Volume	Bid5:29:25 PM	Ask5:32:21 PM	Market Capitalization	Dividend Y.	P/E Ratio
7.97EUR	-0.38%	0 Turnover: -	-Bid Size: -	-Ask Size: -	1.4 bill.EUR	-	-

GlobeNewswire 5/14/2024 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease

GlobeNewswire 1/16/2024 HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and ...

GlobeNewswire 12/11/2023 Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...

GlobeNewswire 11/7/2023 Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline

GlobeNewswire 10/20/2021 Curexsys Appoints Christian Eckert as Chief Operating Officer

GlobeNewswire 10/11/2021 Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement

GlobeNewswire 4/26/2021 Proactive news headlines including Chase Mining Corporation, Red River Resources, Aurumin and Kazia ...

GlobeNewswire 4/20/2021 Proactive news headlines including Queensland Pacific Metals, Moho Resources, Kazia Therapeutics and...

GlobeNewswire 3/1/2021 Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Preci...

GlobeNewswire 8/20/2020 CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease

GlobeNewswire 6/4/2020 Toronto Innovation Acceleration Partners Expands its LAB150 Portfolio with a Novel Cancer Therapeut...

GlobeNewswire 2/12/2020 TIAP announces New President and CEO

GlobeNewswire 12/12/2019 Toronto Innovation Acceleration Partners (TIAP) adds novel KRAS oncology project to its LAB150 portf...

GlobeNewswire 6/11/2019 Mental Health is Focus of New High-Potential Anti-Depression Project from MaRS Innovation and the Ce...

GlobeNewswire 2/7/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis

GlobeNewswire 2/15/2018 EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE

GlobeNewswire 1/8/2018 APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi

GlobeNewswire 9/14/2017 MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO

GlobeNewswire 11/29/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...

GlobeNewswire 11/10/2011 Evotec reports nine months results: Upside materialising

GlobeNewswire 11/3/2011 Evotec to Report Third Quarter Results on 10 November 2011

GlobeNewswire 10/27/2011 Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi

GlobeNewswire 10/20/2011 Evotec and APEIRON Biologics start next project on the Cbl-b target

GlobeNewswire 10/5/2011 Evotec announces second multi-target collaboration with UCB

EVOTEC SE/ DE0005664809 /

If you wish to receive reply to your feedback, please provide your email address.